Stephen J Marx
Overview
Explore the profile of Stephen J Marx including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
2178
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sarquis M, Marx S, Beckers A, Bradwell A, Simonds W, Bicalho M, et al.
Endocrine
. 2019 Nov;
67(1):204-208.
PMID: 31782130
Purpose: Parathyroid cancer is a rare tumor associated with poor prognosis particularly when disseminated. While chemotherapy and/or radiotherapy are of no clinical value in disseminated disease, immunotherapy should be considered....
2.
Marx S, Sinaii N
J Clin Endocrinol Metab
. 2019 Nov;
105(4).
PMID: 31778168
Context: Neonatal severe hyperparathyroidism (NSHPT) is rare and potentially lethal. It is usually from homozygous or heterozygous germline-inactivating CASR variant(s). NSHPT shows a puzzling range of serum calcium and parathyroid...
3.
Marx S
J Clin Endocrinol Metab
. 2019 Mar;
104(9):4058-4066.
PMID: 30848815
Context: Familial isolated hyperparathyroidism (FIHP) is defined as familial primary hyperparathyroidism (FH) without a characteristic extraparathyroidal feature of a more complex hyperparathyroid syndrome. New concepts of FIHP have been developed...
4.
Marx S, Goltzman D
J Bone Miner Res
. 2018 Dec;
34(1):22-37.
PMID: 30536424
We review advancing and overlapping stages for our understanding of the expressions of six hyperparathyroid (HPT) syndromes: multiple endocrine neoplasia type 1 (MEN1) or type 4, multiple endocrine neoplasia type...
5.
Carvalho R, Urtremari B, Jorge A, Santana L, Quedas E, Sekiya T, et al.
Eur J Endocrinol
. 2018 Oct;
179(6):391-407.
PMID: 30324798
Background Loss-of-function germline MEN1 gene mutations account for 75-95% of patients with multiple endocrine neoplasia type 1 (MEN1). It has been postulated that mutations in non-coding regions of MEN1 might...
6.
Marx S, Lourenco Jr D
Front Endocrinol (Lausanne)
. 2018 Aug;
9:359.
PMID: 30065698
No abstract available.
7.
Makri A, Bonella M, Keil M, Hernandez-Ramirez L, Paluch G, Tirosh A, et al.
Clin Endocrinol (Oxf)
. 2018 Jun;
89(4):437-443.
PMID: 29927501
Objective: Cushing disease (CD) is a rare entity caused by ACTH-secreting pituitary tumours, leading to prolonged hypercortisolism. Most cases are sporadic but can rarely occur in the context of familial...
8.
Marx S
J Clin Endocrinol Metab
. 2018 Jun;
103(4):1296-1301.
PMID: 29897580
Introduction: Multiple endocrine neoplasia type 1 (MEN1) is complex with regard to clinical expressions, management, and molecular pathways. Advances are being made broadly and in focused aspects. Selected topics are...
9.
10.
Guan B, Welch J, Vemulapalli M, Li Y, Ling H, Kebebew E, et al.
J Endocr Soc
. 2017 Dec;
1(5):488-499.
PMID: 29264504
Context: Germline gain-of-function variants in the transcription factor GCM2 were found in 18% of kindreds with familial isolated hyperparathyroidism (FIHP). These variants [c.1136T>A (p.Leu379Gln) and c.1181A>C (p.Tyr394Ser)] were located in...